The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

 

Oncology Drug Pipeline Analysis Market

North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030.

The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood cancer. Again in September 2020, a Blueprint Medicines corporation has received FDA approval for cancer drug, making it the latest targeted therapy. Thus, rising such approvals for cancers therapies is propelling the growth of the oncology drug pipeline analysis market.

1.     In April 2019, Sun Pharmaceutical Industries announced the launch of INFUGEM injection, used for the treatment of cancer, in the US market. In July 2018, Sun Pharma had received approval from the US health regulator for INFUGEM injection

2.     In October 2020, AstraZeneca Pharma India Ltd. the launch its Acalabrutinib 100 milligram capsules, used for the treatment of various types of blood cancers, under the brand name 'Calquence'

An oncology drug pipeline analysis is a specialized form of medical research done on human cancer cells. It consists of a high- magnification examination of cancer cells under the microscope, concentrating on their properties such as proliferation, invasion, differentiation, metastasis, and resistance to therapy. A unique feature of oncology pipelines is that they concentrate on oncologist preoperative and postoperative clinical studies in order to establish management of patients with oncology disease. This form of analysis has revolutionized Oncology and is used to improve oncology service delivery. Due to the advancement in analytical techniques and increased use of advanced imaging technologies, Oncology pipelines are now a key component of oncology research. Oncology is one of the fastest-growing cancer specialties in the world with tremendous growth potential in both the public and private markets.

Comments

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis